Pedram Razavi, Ph.D.
Affiliations: | 2009 | Epidemiology | University of Southern California, Los Angeles, CA, United States |
Area:
Epidemiology, Oncology, GeneticsGoogle:
"Pedram Razavi"Parents
Sign in to add mentor| Giske Ursin | grad student | 2009 | USC | |
| (Hormonal and genetic risk factors of endometrial cancer and trends in incidence and survival of adult acute lymphoblastic leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kim S, Armand J, Safonov A, et al. (2023) Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer. Cell Reports. 42: 113198 |
| Nagaraj G, Vinayak S, Khaki AR, et al. (2023) Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) cohort study. Elife. 12 |
| Nagaraj G, Vinayak S, Khaki AR, et al. (2023) Clinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Medrxiv : the Preprint Server For Health Sciences |
| Vahdatinia M, Derakhshan F, Da Cruz Paula A, et al. (2022) genetic alterations in breast cancer. Journal of Clinical Pathology |
| Grabenstetter A, Brogi E, Zhang H, et al. (2022) Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy. Npj Breast Cancer. 8: 93 |
| Lloyd MR, Wander SA, Hamilton E, et al. (2022) Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging role. Therapeutic Advances in Medical Oncology. 14: 17588359221113694 |
| Satyanarayana G, Enriquez KT, Sun T, et al. (2022) Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study. Open Forum Infectious Diseases. 9: ofac037 |
| Nguyen B, Fong C, Luthra A, et al. (2022) Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell. 185: 563-575.e11 |
| Smith AE, Ferraro E, Safonov A, et al. (2021) HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway. Nature Communications. 12: 6667 |
| Schwartz CJ, da Silva EM, Marra A, et al. (2021) Morphological and genomic characteristics of breast cancers occurring in individuals with Lynch Syndrome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |